A Phase I, Randomized, Open-label, 5-way Crossover, Single Centre Study in Healthy Subjects to Assess the Lung Deposition of Inhaled Budesonide Delivered Via Different Inhalation Devices.
Phase of Trial: Phase I
Latest Information Update: 12 Dec 2009
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 12 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Sep 2009 New trial record